What Is CAR T-cell Therapy?
With seven CAR T-cell therapies approved by the U.S. Food and Drug Administration, this innovative immunotherapy has revolutionized the...
Tag: blood cancers
With seven CAR T-cell therapies approved by the U.S. Food and Drug Administration, this innovative immunotherapy has revolutionized the...
The summer issue of Cancer Today includes articles about integrating patient-reported outcomes into clinical research and care, advances in...
Exposure to wildfire smoke may increase the risk of developing several cancers, according to research presented at the AACR...
In the CAR-PRISM clinical trial, the CAR T-cell therapy ciltacabtagene autoleucel showed promise for treating high-risk smoldering myeloma.
Cancer Today's fall issue features articles on the early integration of palliative care for blood cancer patients, accommodating deaf...
This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.
A single-cell atlas helped clarify diverse forms of acute myeloid leukemia, with potential implications for improving diagnostic, prognostic, and...
In the first quarter of 2025, the FDA issued 13 approvals for oncology treatments, covering nine types of cancer...
Multiple myeloma can be tricky to treat, but many treatment options exist, and new research is constantly supporting more.
Our annual Experts Forecast offers insights from AACR President-Elect Lillian Siu, John E. Dick, Regina Barzilay, Vinod Balachandran, and...